featured
JAK Inhibitors as a Novel, Safe, and Effective Therapy for Pyoderma Gangrenosum
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
International Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
JAK inhibitors: a novel, safe, and efficacious therapy for pyoderma gangrenosum
Int. J. Dermatol 2023 Apr 29;[EPub Ahead of Print], LGM CastroFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.